# Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy

> **NCT04109079** · NA · RECRUITING · sponsor: **University Hospitals of Derby and Burton NHS Foundation Trust** · enrollment: 1900 (estimated)

## Conditions studied

- Breast Cancer
- Sentinel Lymph Node
- Neoplasm, Breast

## Interventions

- **PROCEDURE:** Axillary lymph node dissection
- **RADIATION:** Axillary radiotherapy
- **RADIATION:** Breast or chest wall radiotherapy

## Key facts

- **NCT ID:** NCT04109079
- **Lead sponsor:** University Hospitals of Derby and Burton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-26
- **Primary completion:** 2030-02-28
- **Final completion:** 2030-02-28
- **Target enrollment:** 1900 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04109079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04109079, "Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04109079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*